Navigation Links
Cholesterol Drug Fails to Slow Progression of Coronary Disease,,Cleveland Clinic Study Reports

NEW ORLEANS, March 26, 2007 /PRNewswire/ -- Cleveland Clinic researchers today report that the drug torcetrapib, despite raising high density lipoprotein cholesterol (HDL) or the "good" cholesterol by more than 60%, did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe.

Steven Nissen, M.D., Chairman of Cardiovascular Medicine at Cleveland Clinic and lead investigator of this clinical trial, will present the study on Monday, March 26 at 8:30 a.m. at the of Cardiology's (ACC) 56th Annual Scientific Session. Dr. Nissen is also President of the ACC. The study will be simultaneously published in the New England Journal of Medicine.

All development of this drug was terminated on Dec. 2, 2006 after the safety board monitoring a separate large clinical outcomes trial reported that torcetrapib increased the risk of death and other adverse cardiovascular outcomes.

"We found that the torcetrabip/atorvastatin combination markedly increased good cholesterol levels and lowered bad cholesterol in patients. Unfortunately this drug also substantially raised blood pressure and failed to slow the buildup of plaque," Dr. Nissen said. "It is yet to be determined of this failure represents a problem unique to torcetrapib or predicts a lack of efficacy for the entire class of similar drugs. These findings further demonstrate the great difficulty in developing therapies to disrupt the atherosclerotic disease process."

The development of drugs to raise HDL has been a key research priority because, despite lowering LDL (low-density lipoprotein, or "bad") cholesterol with statin drugs, many patients continue to experience heart attacks, stroke or sudden cardiac death.

A total of 1,188 coronary artery disease patients were enrolled in the "Investigation of Lipid Level management using coronary UltraSound To assess Reduction of Atherosclerosis by CET
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Low-Density Cholesterol Subfractions: Not all LDL-C Particles are Created Equal
2. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
3. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
4. KineMed Presents Data Measuring Changes in Reverse Cholesterol Transport for the First Time
5. CSL Therapy That Mimics “Good” Cholesterol May Reduce Plaque Volume in Coronary Arteries
6. CSL Therapy That Mimics Good Cholesterol May Reduce Plaque Volume in Coronary Arteries
7. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
8. Caelyx Delays Time to Disease Progression as Maintenance Therapy in Patients with Metastatic Breast Cancer
9. Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
10. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
11. Multiferon Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published

Post Your Comments:
(Date:11/29/2009)... FUJIFILM Medical Systems USA, Inc...ionary flat panel DR cassette, at the 2009 Radiolo...ng. Ideal for any clinical environment, FDR D-EVO...icians with Fujifilm,s trademark image quality and... way for users to transition to DR without modific...
(Date:11/29/2009)... Stimulated by the ten years of Sy...dical Systems USA announced today, at the Radiolog...g, the formation of its Medical Informatics Divis...w group will integrate all functions associated wi...a platform for future growth. ,, Several organi...
(Date:11/29/2009)... Researchers using functional magn...ation have found that men and women respond differ...to a study presented today at the annual meeting o.... ,, "Men may direct more attention to sensory ...hem in terms of implications for required action, ...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Spaghetti scaffolding could help grow skin in labs 10400 1Spaghetti scaffolding could help grow skin in labs 10400 2Targacepts P 2b depression study succeeds 3A 6 point difference on HAM D 10395 1Targacepts P 2b depression study succeeds 3A 6 point difference on HAM D 10395 2Targacepts P 2b depression study succeeds 3A 6 point difference on HAM D 10395 3BCS Global Completes Polycom Telepresence VNOC 28Video Network Operations Center 29 Provider Program 59636 1BCS Global Completes Polycom Telepresence VNOC 28Video Network Operations Center 29 Provider Program 59636 2BCS Global Completes Polycom Telepresence VNOC 28Video Network Operations Center 29 Provider Program 59636 3
...SBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Jun 21, 20...X) today announced that,detailed results from the ...r benign prostatic hyperplasia (BPH) will be prese..., beginning in September,at the South Central Amer...rings. These independent podium presentations will...
...HICAGO, June 21, 2007 /PRNewswire/ -- , What and W...of ACTOS(R),(pioglitazone HCl) will be presented i... the American Diabetes Association in,Chicago: , ,... in high-risk type 2, diabetes patients tre... PROactive; Poster 0553-P presented on Satur...
Other Medicine Technology:Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating,MacroVascular Outcomes Presented at the American Diabetes,Association 67th Scientific Sessions 2MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating,MacroVascular Outcomes Presented at the American Diabetes,Association 67th Scientific Sessions 3
(Date:11/30/2009)... , CHICAGO Middle-aged men and women who engage ...ngly causing damage to their knees and increasing ...y presented today at the annual meeting of the Rad...r data suggest that people with higher physical ac...g knee abnormalities and, thus, at higher risk for...
(Date:11/30/2009)... , , DALLAS Nov. 30, 2009 UT Southwestern Medic...lts can help families stave off complications asso... and in the December issue of Pediatrics, sugges... of asthmatic children who have received specializ...ng, asthma attacks, emergency room visits and miss...
(Date:11/29/2009)... , The Academy of General...of Orange county CA, received the Mastership Award...cognizes AGD members, commitment to excellence in ...completed 1,100 hours of approved continuing denta...cluding 400 hours dedicated to hands-on skills and...
(Date:11/29/2009)... Witnessing someone get blamed for something lead...nds , , SUNDAY, Nov. 29 (HealthDay News)...y reports, even when the target is innocent. , ...me someone else for a problem, even if it,s an unf... in blaming others, too. , "When we see others...
(Date:11/29/2009)... , Traditional healthcare... for viable affordable alternative care. Affordabl... (PRWEB) November 29, 2009 -- A... June of this year (2009) and has been met with en...and rapid success can be attributed to two things,...
Breaking Medicine News(10 mins):Health News:Too much physical activity may lead to arthritis 2Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:When Accusations Start to Fly, They Multiply 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2
...cademy,of Orthopaedic Surgeons (AAOS) has approved...guideline on "The Treatment of Carpal Tunnel Syndr...s CTS, is among the most,common disorders of the u...e median nerve in the carpal tunnel in the,wrist,"...
...urns Your Compassion into Life,Changing Solutions,...e long lines and steep price tags at the departmen...ers --- like helping a blind child in,Nepal see ag... season by sending Gifts of Service(R) cards from ...
...versity Cell and DNA Repository (RUCDR) has receiv...from the National Institutes of Health (NIH). One ...the other will support investigations into the cau...ntific merit of the proposals and the past experie...
...bout 5 million people in the United States suffer ...te that changes to diet can reduce HF risk, few la... new study researchers observed over 14,000 partic... groups did not directly affect HF risk. The resul...
...omberg School of Public Health have been selected ...o understand patterns of disability and aging. The...tional Institutes of Health, is expected to award ...f Medicine & Dentistry of New Jersey, Brown Univer...
...enefits to improve care and quality of life for M...ns -, COLUMBIA, S.C., Oct. 27 In preparation for...ich begins November 15th, Care,Improvement Plus to...hancements to added benefits and care management,s...
Other Medicine News:Health News:AAOS Issues New Treatment Guidelines for Carpal Tunnel Syndrome 2Health News:This Holiday Season, Give a Gift that Does a World of Good 2Health News:NIH awards Rutgers Cell and DNA Repository $57.8M 2Health News:Eating whole grains lowers heart failure risk, according to new study 2Health News:Bloomberg School of Public Health to lead nationwide aging study 2Health News:Care Improvement Plus Launches 2009 Benefits in South Carolina 2
Three-mirror Contact Lens 907
Three-mirror Contact Lens 906
...l conditions in the area of the front of the iris....n only be ascertained by employing a narrow slit b...clinable illumination, is primarily capable of pro...angle of the iris, which is of special importance ...
Retrograde Nail
Medicine Products: